Core Insights - Gujing Gongjiu's stock price increased by 2.18% on November 20, reaching 164.05 CNY per share, with a total market capitalization of 86.717 billion CNY [1] - The company reported a year-to-date stock price decline of 1.94%, with a 5-day decline of 1.48%, a 20-day increase of 5.63%, and a 60-day increase of 1.70% [1] - For the period from January to September 2025, Gujing Gongjiu's revenue was 16.425 billion CNY, a year-on-year decrease of 13.87%, and the net profit attributable to shareholders was 3.960 billion CNY, down 16.57% year-on-year [2] Financial Performance - The company has distributed a total of 12.612 billion CNY in dividends since its A-share listing, with 7.136 billion CNY distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included major institutional investors, with notable changes in holdings among them [3] Shareholder Information - As of November 10, 2025, the number of shareholders decreased by 0.80% to 46,000, with an average of 0 circulating shares per shareholder [2] - Significant changes in institutional holdings were noted, with some funds increasing their positions while others reduced their stakes [3]

Core Viewpoint - Jin Chengxin's stock price has increased by 76.57% year-to-date, but has seen a decline of 3.93% in the last five trading days and 2.10% in the last twenty days, while experiencing a 20.16% increase over the last sixty days [2] Company Overview - Jin Chengxin Mining Management Co., Ltd. is located in Fengtai District, Beijing, established on January 7, 2008, and listed on June 30, 2015. The company specializes in mining engineering construction, mining operation management, mining design, and technology research and development [2] - The main business revenue composition includes: sales of cathode copper, copper concentrate, and phosphate rock (46.11%), mining operation management (39.63%), mining engineering construction (11.85%), materials, equipment, and others (1.29%), mining machinery and equipment (1.00%), and mining design consulting (0.13%) [2] Financial Performance - For the period from January to September 2025, Jin Chengxin achieved operating revenue of 9.933 billion yuan, representing a year-on-year growth of 42.50%, and a net profit attributable to shareholders of 1.753 billion yuan, reflecting a year-on-year increase of 60.37% [2] - Since its A-share listing, Jin Chengxin has distributed a total of 768 million yuan in dividends, with 477 million yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of Jin Chengxin shareholders reached 20,900, an increase of 27.38% from the previous period, with an average of 29,884 circulating shares per person, a decrease of 21.49% [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the second-largest shareholder with 24.4684 million shares, an increase of 10.5752 million shares from the previous period. The Southern CSI 500 ETF (510500) is the tenth-largest shareholder with 5.4639 million shares, marking a new entry [3]

Core Viewpoint - The stock of Jinchengxin has shown significant volatility, with a year-to-date increase of 74.56% but a recent decline in the last five trading days by 3.56% [1] Company Overview - Jinchengxin Mining Management Co., Ltd. is based in Fengtai District, Beijing, and was established on January 7, 2008, with its listing date on June 30, 2015 [1] - The company specializes in mining development services, including mining engineering construction, mining operation management, and mining design and technology research [1] - The revenue composition includes sales of cathode copper, copper concentrate, and phosphate rock (46.11%), mining operation management (39.63%), mining engineering construction (11.85%), materials and equipment (1.29%), mining machinery (1.00%), and mining design consulting (0.13%) [1] Financial Performance - For the period from January to September 2025, Jinchengxin achieved a revenue of 9.933 billion yuan, representing a year-on-year growth of 42.50%, and a net profit attributable to shareholders of 1.753 billion yuan, up 60.37% year-on-year [2] - Cumulative cash dividends since the A-share listing amount to 768 million yuan, with 477 million yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 20,900, a rise of 27.38%, while the average circulating shares per person decreased by 21.49% to 29,884 shares [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 24.4684 million shares, an increase of 10.5752 million shares from the previous period [3] - The Southern CSI 500 ETF is a new entrant among the top ten circulating shareholders, holding 5.4639 million shares [3] Market Activity - As of November 19, Jinchengxin's stock price was 62.58 yuan per share, with a trading volume of 279 million yuan and a turnover rate of 0.73%, leading to a total market capitalization of 39.036 billion yuan [1] - The net outflow of main funds was 56.8995 million yuan, with large orders accounting for 19.25% of purchases and 38.52% of sales [1]

11月19日，福斯达盘中下跌2.00%，截至09:54，报38.67元/股，成交2374.38万元，换手率1.23%，总市 值61.87亿元。 资金流向方面，主力资金净流出198.39万元，特大单买入0.00元，占比0.00%，卖出290.17万元，占比 12.22%；大单买入499.60万元，占比21.04%，卖出407.81万元，占比17.18%。 福斯达今年以来股价涨71.45%，近5个交易日跌2.37%，近20日跌17.32%，近60日跌18.52%。 今年以来福斯达已经1次登上龙虎榜，最近一次登上龙虎榜为4月22日。 资料显示，杭州福斯达深冷装备股份有限公司位于浙江省杭州市临平区杭州临平经济技术开发区兴起路 398号，成立日期2000年7月4日，上市日期2023年1月30日，公司主营业务涉及专业从事各类深冷技术工 艺的开发及深冷装备的设计、制造和销售,为客户提供深冷系统整体解决方案。主营业务收入构成为： 空分设备71.40%，天然气处理及液化装置23.13%，其他5.46%，租赁收入0.01%。 福斯达所属申万行业为：机械设备-专用设备-能源及重型设备。所属概念板块包括：价值成长、专精特 新、基金重 ...

Core Viewpoint - Dongpeng Beverage's stock has experienced a decline recently, with a notable drop in trading volume and net outflow of funds, indicating potential investor concerns about the company's performance and market sentiment [1][2]. Company Overview - Dongpeng Beverage Group Co., Ltd. was established on June 30, 1994, and went public on May 27, 2021. The company is primarily engaged in the research, production, and sales of beverages [2]. - The main revenue composition includes energy drinks (77.87%), electrolyte drinks (13.90%), and other beverages (8.17%) [2]. - As of September 30, the number of shareholders increased by 21.82% to 16,000, while the average circulating shares per person decreased by 17.91% to 32,533 shares [2]. Financial Performance - For the period from January to September 2025, Dongpeng Beverage achieved a revenue of 16.844 billion yuan, representing a year-on-year growth of 34.13%. The net profit attributable to shareholders was 3.761 billion yuan, with a year-on-year increase of 38.91% [2]. - Since its A-share listing, the company has distributed a total of 6.6 billion yuan in dividends, with 5.4 billion yuan distributed over the past three years [3]. Stock Market Activity - As of November 18, Dongpeng Beverage's stock price was 256.13 yuan per share, with a market capitalization of 133.191 billion yuan. The stock has seen a year-to-date increase of 5.18%, but has declined by 7.90% over the last five trading days and 14.91% over the last 20 days [1]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on February 21, where it recorded a net buy of -389 million yuan [1].

Core Viewpoint - Chengdu Bank's stock price has experienced a decline, with a current trading price of 16.71 CNY per share, reflecting a 2.05% drop on November 17. The bank's market capitalization stands at 70.824 billion CNY [1]. Group 1: Stock Performance - Chengdu Bank's stock has increased by 3.03% year-to-date, but has seen a decline of 2.22% over the last five trading days, 9.28% over the last 20 days, and 8.24% over the last 60 days [1]. - The trading volume on November 17 reached 664 million CNY, with a turnover rate of 0.93% [1]. Group 2: Financial Metrics - For the period from January to September 2025, Chengdu Bank reported a net profit attributable to shareholders of 9.493 billion CNY, representing a year-on-year growth of 5.03% [1]. - The bank has distributed a total of 17.856 billion CNY in dividends since its A-share listing, with 10.126 billion CNY distributed over the past three years [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders of Chengdu Bank increased by 19.69% to 53,400, while the average circulating shares per person decreased by 16.45% to 79,262 shares [1]. - Hong Kong Central Clearing Limited is the third-largest circulating shareholder, holding 255.7 million shares, an increase of 9.7744 million shares from the previous period [2].

资金流向方面，主力资金净流出1719.46万元，特大单买入363.09万元，占比2.11%，卖出784.81万元， 占比4.55%；大单买入2475.88万元，占比14.36%，卖出3773.62万元，占比21.89%。 海信家电今年以来股价跌5.32%，近5个交易日跌2.38%，近20日涨4.51%，近60日涨7.55%。 11月17日，海信家电盘中下跌2.02%，截至13:43，报26.20元/股，成交1.72亿元，换手率0.71%，总市值 362.83亿元。 资料显示，海信家电集团股份有限公司位于广东省佛山市顺德区容桂街道容港路8号，成立日期1997年4 月21日，上市日期1999年7月13日，公司主营业务涉及冰箱、空调器及家用电器的制造和销售。主营业 务收入构成为：暖通空调48.02%，冰洗31.20%，其他主营13.40%，其他(补充)7.38%。 机构持仓方面，截止2025年9月30日，海信家电十大流通股东中，香港中央结算有限公司位居第四大流 通股东，持股2689.05万股，相比上期减少132.86万股。南方中证500ETF（510500）位居第七大流通股 东，持股673.42万股，相比上期减少9 ...

11月17日，齐鲁银行盘中下跌2.10%，截至13:22，报6.07元/股，成交2.23亿元，换手率0.59%，总市值 373.54亿元。 资金流向方面，主力资金净流入2190.11万元，特大单买入3202.11万元，占比14.36%，卖出2721.89万 元，占比12.21%；大单买入5476.80万元，占比24.56%，卖出3766.92万元，占比16.90%。 截至9月30日，齐鲁银行股东户数5.61万，较上期增加30.16%；人均流通股109647股，较上期减少 7.07%。2025年1月-9月，齐鲁银行实现营业收入0.00元；归母净利润39.63亿元，同比增长15.14%。 分红方面，齐鲁银行A股上市后累计派现48.72亿元。近三年，累计派现32.05亿元。 机构持仓方面，截止2025年9月30日，齐鲁银行十大流通股东中，香港中央结算有限公司位居第十大流 通股东，持股1.28亿股，相比上期减少87.65万股。 责任编辑：小浪快报 齐鲁银行今年以来股价涨14.01%，近5个交易日跌2.10%，近20日跌1.62%，近60日涨3.06%。 资料显示，齐鲁银行股份有限公司位于山东省济南市历下区经十路108 ...

四川黄金今年以来股价涨31.99%，近5个交易日跌1.34%，近20日跌2.37%，近60日涨16.77%。 今年以来四川黄金已经1次登上龙虎榜，最近一次登上龙虎榜为4月11日，当日龙虎榜净买入2122.34万 元；买入总计1.97亿元 ，占总成交额比12.71%；卖出总计1.76亿元 ，占总成交额比11.34%。 资料显示，四川黄金股份有限公司位于四川省成都市高新区天泰路145号，成立日期2006年8月16日，上 市日期2023年3月3日，公司主营业务涉及主要从事金矿的采选及销售,主要产品为金精矿和合质金。主 营业务收入构成为：金精矿100.00%。 11月17日，四川黄金盘中下跌2.05%，截至11:25，报27.23元/股，成交1.64亿元，换手率2.07%，总市值 114.37亿元。 资金流向方面，主力资金净流出1109.57万元，特大单买入521.70万元，占比3.19%，卖出1107.29万元， 占比6.77%；大单买入2658.64万元，占比16.25%，卖出3182.62万元，占比19.46%。 分红方面，四川黄金A股上市后累计派现3.36亿元。 机构持仓方面，截止2025年9月30日，四川黄 ...

Core Viewpoint - Zhaoli Pharmaceutical's stock has experienced a decline of 2.05% on November 17, with a current price of 17.23 CNY per share and a market capitalization of 12.085 billion CNY, despite a year-to-date increase of 16.67% [1] Financial Performance - For the period from January to September 2025, Zhaoli Pharmaceutical reported a revenue of 2.28 billion CNY, reflecting a year-on-year growth of 11.48%, and a net profit attributable to shareholders of 510 million CNY, which is a 21.00% increase compared to the previous year [2] - Cumulative cash dividends since the company's A-share listing amount to 1.442 billion CNY, with 942 million CNY distributed over the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 41,400, up by 7.31%, while the average number of circulating shares per person decreased by 6.82% to 14,562 shares [2] - Among the top ten circulating shareholders, the "Innovative Medicine" fund holds 6.8549 million shares, an increase of 280,700 shares, while the "Southern CSI 1000 ETF" holds 6.4172 million shares, a decrease of 58,800 shares [3] Stock Performance - Zhaoli Pharmaceutical's stock has seen a decline of 2.43% over the last five trading days, 6.92% over the last twenty days, and 13.29% over the last sixty days [1] - The stock's trading volume on November 17 was 58.7402 million CNY, with a turnover rate of 0.56% [1] Business Overview - Zhaoli Pharmaceutical, established on January 28, 2000, and listed on February 22, 2011, specializes in the research, production, and sales of medicinal fungi, traditional Chinese medicine pieces, and formula granules [1] - The company's main revenue sources include the Wuling series (56.07%), traditional Chinese medicine pieces (21.85%), and other products [1] Industry Classification - Zhaoli Pharmaceutical is classified under the pharmaceutical and biotechnology sector, specifically in traditional Chinese medicine [1] - The company is associated with various concept sectors, including value growth, cell therapy, precision medicine, cancer treatment, and innovative drugs [1]